ACCURASEE PACKAGING & LABELING - Trademark Details
Status: 809 - SU - Final Refusal - Mailed
Serial Number
87756940
Word Mark
ACCURASEE PACKAGING & LABELING
Status
809 - SU - Final Refusal - Mailed
Status Date
2021-08-26
Filing Date
2018-01-16
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
261709, 261713 - Curved line(s), band(s) or bar(s). Letters or words underlined and/or overlined by one or more strokes or lines.
Published for Opposition Date
2018-06-19
Attorney Name
Law Office Assigned Location Code
M80
Employee Name
LEASER, ANDREW C
Statements
Indication of Colors claimed
The colors black and red are claimed as a feature of the mark.
Disclaimer with Predetermined Text
"PACKAGING & LABELING"
Description of Mark
The mark consists of the wording "AccuraSEE" in larger italicized font and the wording "PACKAGING & LABELING" in smaller font below the right portion of the wording "AccuraSEE". The term "Accura" is in black and the terms "SEE" and "PACKAGING & LABELING" are in red. The slash in the first letter "A" in "Accura" curves down and across the entire lower portion of the mark.
Goods and Services
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, oncological, neurological, gastrointestinal, hormonal, psychiatric and immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Dermatological pharmaceutical products; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the treatment of joint disease; Intravenous fluids used for the delivery of pharmaceutical preparations; Intravenous bags, syringes, and vials sold filled with injectable pharmaceutical preparations, namely, oncologic products and ancillary products, chemotherapy agents, anti-emitics, and anti-infectives; Anticholinergics; Anticholinesterases; Anti-hypotensives; Biological preparations for the treatment of cancer; Anesthetics for surgical and non-surgical use; Antibiotics; Antiemetics; Sedatives; all of the foregoing featuring differentiated packaging for the purpose of reducing user errors and promoting correct medication selection
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-01-28
Primary Code
005
First Use Anywhere Date
2017-02-21
First Use In Commerce Date
2017-02-21
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Christopher M. Thomas
Address
Please log in with your Justia account to see this address.
Madrid International Filings
Entry Number
1
Reference Number
A0077290
Original Filing Date USPTO
2018-07-10
International Registration Number
1423104
International Registration Date
2018-07-10
International Status Code
480
International Renewal Date
2028-07-10
Madrid History Events | ||
Date | Code | Description |
2018-07-10 | NEWAP | NEW APPLICATION FOR IR RECEIVED |
2018-07-10 | ACERT | AUTOMATICALLY CERTIFIED |
2018-07-10 | APPST | IR CERTIFIED AND SENT TO IB |
2018-09-13 | CREAT | APPLICATION FOR IR REGISTERED BY IB |
Trademark Events
Event Date | Event Description |
2018-01-19 | NEW APPLICATION ENTERED IN TRAM |
2018-01-28 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2018-01-30 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
2018-04-26 | ASSIGNED TO EXAMINER |
2018-05-01 | EXAMINERS AMENDMENT -WRITTEN |
2018-05-01 | EXAMINERS AMENDMENT E-MAILED |
2018-05-01 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2018-05-01 | EXAMINER'S AMENDMENT ENTERED |
2018-05-01 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2018-05-11 | ASSIGNED TO LIE |
2018-05-11 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2018-05-30 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2018-06-19 | PUBLISHED FOR OPPOSITION |
2018-06-19 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2018-08-14 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2019-02-07 | TEAS EXTENSION RECEIVED |
2019-02-07 | EXTENSION 1 FILED |
2019-02-07 | EXTENSION 1 GRANTED |
2019-02-09 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2019-08-09 | TEAS EXTENSION RECEIVED |
2019-08-09 | EXTENSION 2 FILED |
2019-08-09 | EXTENSION 2 GRANTED |
2019-08-13 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2020-02-10 | TEAS EXTENSION RECEIVED |
2020-02-10 | EXTENSION 3 FILED |
2020-02-10 | EXTENSION 3 GRANTED |
2020-02-12 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2020-08-05 | TEAS EXTENSION RECEIVED |
2020-08-05 | EXTENSION 4 FILED |
2020-08-05 | EXTENSION 4 GRANTED |
2020-08-07 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-02-10 | TEAS STATEMENT OF USE RECEIVED |
2021-02-10 | TEAS EXTENSION RECEIVED |
2021-02-25 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2021-02-10 | EXTENSION 5 FILED |
2021-02-25 | EXTENSION 5 GRANTED |
2021-02-10 | USE AMENDMENT FILED |
2021-02-25 | STATEMENT OF USE PROCESSING COMPLETE |
2021-02-26 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-03-01 | ASSIGNED TO LIE |
2021-03-18 | SU - NON-FINAL ACTION - WRITTEN |
2021-03-18 | NON-FINAL ACTION E-MAILED |
2021-03-18 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2021-07-26 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-07-26 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-07-27 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-08-26 | SU - FINAL REFUSAL - WRITTEN |
2021-08-26 | FINAL REFUSAL E-MAILED |
2021-08-26 | NOTIFICATION OF FINAL REFUSAL EMAILED |